Table 2.
Patient demographics and baseline characteristics at time of first relapse (n=68).
Characteristic (n=68) | absolute | relative | ||
---|---|---|---|---|
Gender | ||||
Male | 52 | 76.5% | ||
Female | 16 | 23.5% | ||
Age | ||||
Median age at diagnosis, years (range) | 62 (40.0-82.0) | |||
Extent of disease at relapse | ||||
Limited disease | 12 | 17.6% | ||
Extensive disease | 56 | 82.4% | ||
Second-line systemic therapy | ||||
No second-line chemotherapy | 26 | 38.2% | ||
Second-line chemotherapy | 44 | 61.8% | ||
Metastases (n=68) | ||||
Liver | 31 | 45.6% | ||
Bone | 34 | 50.0% | ||
Adrenal gland | 23 | 33.8% | ||
Brain | 31 | 45.6% | ||
Smoking | ||||
Current smoker | 47 | 69.1% | ||
Former smoker | 20 | 29.4% | ||
Unknown | 1 | 1.5% | ||
Median number of pack-years (range) | 50 (20-120) | |||
ECOG Performance status* | ||||
ECOG 0-1 | 39 | |||
ECOG ≥2 | 6 | |||
ECOG, Eastern Cooperative Oncology Group
*Data for performance status missing for 42 patients